title: Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease.
authors.affiliation: Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892.
authors.forename: N H
authors.initials: NH
authors.lastname: Greig
authors.forename: X F
authors.initials: XF
authors.lastname: Pei
authors.forename: T T
authors.initials: TT
authors.lastname: Soncrant
authors.forename: D K
authors.initials: DK
authors.lastname: Ingram
authors.forename: A
authors.initials: A
authors.lastname: Brossi
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010830:Physostigmine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D013329:Structure-Activity Relationship
chemical_list: D002800:Cholinesterase Inhibitors; C092643:physovenine; D010830:Physostigmine; C092280:phenserine